MONTREAL and CHARLOTTE, N.C., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results for the third quarter ending September 30, 2025, and ...
Revenues of $85.5 million; Operating income of $3.8 million on a GAAP basis, or $5.3 million on a non-GAAP basis; Net income of $0.0 million on a GAA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback